LDHC and hepatocellular carcinoma: Notably, LDHC-silenced HCC-1954 cells demonstrated a higher cell viability than their control counterparts, likely resulting from the activation of the pro-oncogenic STAT3 signaling pathway, which could be reversed by STAT3 inhibition (Figure 4B—left).